Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V A Johnson

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Journal of Clinical Pharmacology|February 1, 1989
Flurbiprofen in post-partum women: plasma and breast milk dispositionI J Smith, J L Hinson, V A Johnson, et al.
AIDS (London, England)|February 1, 1997
Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working GroupA N Phillips, J Eron, J Bartlett, et al.
Animal Behaviour|July 4, 2017
Male great tits assort by personality during the breeding seasonKaterina V-A Johnson, Lucy M Aplin, Ella F Cole, et al.
Journal of Clinical Microbiology|July 6, 2000
Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptaseG J Hanna, V A Johnson, D R Kuritzkes, et al.
The Journal of Infectious Diseases|March 18, 2000
Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapineG J Hanna, V A Johnson, D R Kuritzkes, et al.
AIDS (London, England)|May 12, 2000
Absence of virological changes after acute febrile illnesses in two patients with undetectable pre-illness plasma HIV-1-RNA levelsB E Sha, V A Johnson, M A Kendall, et al.
AIDS Research and Human Retroviruses|October 6, 2000
Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimensP B Gilbert, G J Hanna, V De Gruttola, et al.
The Journal of Infectious Diseases|October 1, 1991
Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitroV A Johnson, D P Merrill, J A Videler, et al.
The Journal of Infectious Diseases|June 3, 1999
Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North CarolinaS A Fiscus, A A Adimora, V J Schoenbach, et al.
Virology|June 12, 1999
Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 polH F Günthard, A J Leigh-Brown, R T D'Aquila, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Journal of Clinical Pharmacology|February 1, 1989
Flurbiprofen in post-partum women: plasma and breast milk dispositionI J Smith, J L Hinson, V A Johnson, et al.
AIDS (London, England)|February 1, 1997
Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working GroupA N Phillips, J Eron, J Bartlett, et al.
Animal Behaviour|July 4, 2017
Male great tits assort by personality during the breeding seasonKaterina V-A Johnson, Lucy M Aplin, Ella F Cole, et al.
Journal of Clinical Microbiology|July 6, 2000
Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptaseG J Hanna, V A Johnson, D R Kuritzkes, et al.
The Journal of Infectious Diseases|March 18, 2000
Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapineG J Hanna, V A Johnson, D R Kuritzkes, et al.
AIDS (London, England)|May 12, 2000
Absence of virological changes after acute febrile illnesses in two patients with undetectable pre-illness plasma HIV-1-RNA levelsB E Sha, V A Johnson, M A Kendall, et al.
AIDS Research and Human Retroviruses|October 6, 2000
Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimensP B Gilbert, G J Hanna, V De Gruttola, et al.
The Journal of Infectious Diseases|October 1, 1991
Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitroV A Johnson, D P Merrill, J A Videler, et al.
The Journal of Infectious Diseases|June 3, 1999
Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North CarolinaS A Fiscus, A A Adimora, V J Schoenbach, et al.
Virology|June 12, 1999
Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 polH F Günthard, A J Leigh-Brown, R T D'Aquila, et al.
Pageof 10